NCT02360215 2025-04-23
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
NRG Oncology
Phase 3 Completed
Clinical Trials
9 trialsNCT02073968 2024-01-25
PAINT
Albert Einstein College of Medicine
Phase 2 Completed
NCT00895622 2023-09-08
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Radiation Therapy Oncology Group
Phase 2 Completed
NCT01730950 2022-12-29
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Radiation Therapy Oncology Group
Phase 2 Completed
NCT04178330 2019-11-26
Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases
ChineseAMS
Phase NA Completed
NCT00238264 2019-08-07
Radiation Therapy in Treating Young Patients With Gliomas
Children's Oncology Group
Phase 2 Completed
NCT01227954 2017-09-27
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00328575 2016-10-21
Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases
Thomas Jefferson University
Phase 1 Completed
NCT00128986 2016-04-06
Study of Tomotherapy in Patients With Benign Brain Tumour
AHS Cancer Control Alberta
Phase 1 Completed